Location History:
- Palo Alto, CA (US) (2019)
- San Jose, CA (US) (2020)
Company Filing History:
Years Active: 2019-2020
Title: Innovations by Jennifer H Yearley
Introduction
Jennifer H Yearley is a prominent inventor based in San Jose, CA. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies for cancer treatment. With a total of 2 patents, her work is paving the way for advancements in immunotherapy.
Latest Patents
One of her latest patents is titled "Antibody that binds to human programmed death ligand 2 (PD-L2) and uses thereof." This patent provides antibodies and antigen binding fragments that specifically target human programmed death ligand 2 (PD-L2). The invention includes nucleic acids encoding these antibodies and host cells transformed with them. These antibodies are instrumental in methods for the immunohistochemical detection of human PD-L2 expression in tissue samples.
Another significant patent is the "Immunohistochemical proximity assay for PD-1 positive cells and PD-ligand positive cells in tumor tissue." This patent describes an assay for detecting and quantifying spatially proximal pairs of PD-1-expressing cells and PD-Ligand-expressing cells in tumor tissue. The assay is designed to generate proximity biomarkers that predict which cancer patients are most likely to benefit from treatment with a PD-1 antagonist.
Career Highlights
Jennifer is currently employed at Merck Sharp & Dohme Corporation, where she continues to innovate in the field of cancer research. Her work is crucial in developing therapies that can improve patient outcomes.
Collaborations
Throughout her career, Jennifer has collaborated with notable colleagues, including Robert H Pierce and Scott P Turner. These collaborations have further enhanced her research and contributions to the field.
Conclusion
Jennifer H Yearley is a trailblazer in the biotechnology sector, with her patents reflecting her commitment to advancing cancer treatment. Her innovative work continues to inspire and lead to new possibilities in medical science.